Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Modern Rheumatology|May 3, 2017
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumabYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
The Journal of Rheumatology|June 17, 2016
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort StudyYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
Clinical Rheumatology|June 11, 2019
Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritisYoshikazu Ogawa, Nobunori Takahashi, Atsushi Kaneko, et al.
Rheumatology (Oxford, England)|October 24, 2014
Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry studyNobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, et al.
Modern Rheumatology|July 14, 2017
Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort studyShuji Asai, Takayoshi Fujibayashi, Takeshi Oguchi, et al.
Modern Rheumatology|September 6, 2011
Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) studyToshihisa Kojima, Atsushi Kaneko, Yuji Hirano, et al.
Modern Rheumatology|September 18, 2018
Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry systemNobunori Takahashi, Toshihisa Kojima, Daihei Kida, et al.
Clinical Rheumatology|May 19, 2019
Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysisNobunori Takahashi, Toshihisa Kojima, Daihei Kida, et al.
The Journal of Rheumatology|April 3, 2015
Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeksNobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, et al.
Modern Rheumatology|October 27, 2012
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritisToshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, et al.
Pageof 10